Recombinant DNA Technology Global Market Report 2025

Description

Recombinant DNA technology denotes the fusion of DNA molecules from diverse organisms, integrating them into a host organism to create new genetic combinations beneficial across scientific, medical, agricultural, and industrial domains. This technology plays a pivotal role in addressing health concerns by facilitating the development of novel medications and vaccines.

Within the realm of recombinant DNA technology, key product categories encompass recombinant protein drugs, vaccines, genetically modified crops, expression systems, cell and gene therapy, and gene editing. Notably, recombinant protein drugs serve crucial roles in biochemical analysis and medical diagnostics within human healthcare, including the production of antibodies, medicines, and vaccines. Renowned for their potency and rapid development compared to small molecules, these drugs are considered safer due to their reduced off-target adverse effects. This category comprises components like expression systems and cloning vectors. The extensive applications of recombinant DNA technology span various sectors such as food and agriculture, health and disease management, environmental interventions, and other diverse areas. This technology finds practical usage in biotechnology and pharmaceutical companies, academic and government research institutions, and various other end-use industries. Its impact is notably significant across a wide spectrum of fields and industries.

The recombinant DNA technology market research report is one of a series of new reports from The Business Research Company that provides recombinant DNA technology market statistics, including recombinant DNA technology industry global market size, regional shares, competitors with an recombinant DNA technology market share, detailed recombinant DNA technology market segments, market trends and opportunities, and any further data you may need to thrive in the recombinant DNA technology industry. This recombinant DNA technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The recombinant DNA technology market size has grown strongly in recent years. It will grow from $858.94 billion in 2024 to $920.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to healthcare demands, biopharmaceutical industry growth, rising investments in R&D, emergence of personalized medicine.

The recombinant DNA technology market size is expected to see strong growth in the next few years. It will grow to $1318.72 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to rising chronic diseases, emerging biotech startups, increasing funding in biotech, globalization of biotech markets, consumer acceptance and education. Major trends in the forecast period include scientific advancements, gene editing advancements, cell and gene therapies, development of RNA therapeutics, therapeutic applications in rare diseases, AI and data integration.

The rising prevalence of chronic diseases is anticipated to drive the growth of the recombinant DNA technology market. Chronic diseases, defined as conditions lasting a year or more that require ongoing medical attention or limit daily activities, significantly impact healthcare needs. Recombinant DNA technology has transformed healthcare by enabling the development of biopharmaceutical proteins used in medications and facilitating gene therapy to replace defective genes with healthy ones, aiming for disease cures. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that by 2050, there would be over 35 million new cancer cases, reflecting a 77% increase from the estimated 20 million cases in 2022. Thus, the rise in chronic diseases is propelling the growth of the recombinant DNA technology market.

The growing advancement of genetically modified crops is projected to drive the expansion of the recombinant DNA technology market in the future. Genetically modified crops are plants that have been intentionally altered at the genetic level using biotechnological methods. Recombinant DNA (rDNA) technology is utilized in the development of genetically modified (GM) crops by isolating genes that provide desired traits, creating recombinant DNA, inserting it into host crop cells, selecting and screening for successful integrations, regenerating transgenic plants, verifying trait expression, conducting field trials, securing regulatory approvals, and ultimately commercializing crops with enhanced characteristics. For example, in December 2023, the United States Department of Agriculture, a US-based government agency, reported that Canada planted 11.7 million hectares of genetically engineered (GE) crops, mainly including canola, soybeans, and corn. This marks a four percent increase from the previous year, largely due to the expansion of canola planting areas. Consequently, the growing development of genetically modified crops is fueling the growth of the recombinant DNA technology market.

Technological advancement is a significant trend within the recombinant DNA technology market. Leading companies in this sector are concentrating on innovative technologies to maintain their competitive edge. For example, in August 2022, Bluebird Bio, Inc., a US-based biotechnology firm, introduced ZYNTEGLO, which received approval from the U.S. Food and Drug Administration (FDA). This one-time gene therapy addresses beta-thalassemia by targeting its genetic cause, providing patients with the opportunity to achieve independence from regular red blood cell transfusions. ZYNTEGLO utilizes an ex-vivo lentiviral vector to modify patient cells and is the first FDA-approved gene therapy for this condition in the United States. This groundbreaking therapy significantly alleviates the lifelong burden associated with managing beta-thalassemia.

Moreover, major players within the recombinant DNA technology sector are actively engaged in developing new vaccines to sustain their market presence. For instance, Variation Biotechnologies Inc. launched PreHevbrio(TM) [Hepatitis B Vaccine (Recombinant)] in March 2022 in the United States. This vaccine, approved by the FDA in November 2021, incorporates essential hepatitis B surface antigens, ensuring a robust immune response when administered in a 3-dose series. The development and launch of such vaccines represent a significant stride within the recombinant DNA technology market.

In January 2022, Thermo Fisher Scientific, a prominent supplier based in the US specializing in scientific instrumentation, reagents, consumables, and software services, finalized the acquisition of PeproTech for a sum of $1.85 billion. This strategic acquisition aimed to complement Thermo Fisher's existing line of cell culture media products by integrating PeproTech's extensive portfolio of recombinant proteins. By combining these offerings, Thermo Fisher sought to deliver enhanced advantages to its customers through an integrated solution. PeproTech, Inc., the acquired company, is recognized for its expertise as a US-based developer and manufacturer of bioscience reagents, particularly renowned for its recombinant proteins.

Major companies operating in the recombinant DNA technology market are Profacgen BioTech Corp., Amgen Inc., Novartis International AG, GenScript Biotech Corporation, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Co. Inc., Biogen Inc., GlaxoSmithKline PLC, New England Biolabs Inc., Bayer CropScience, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc., Gilead Sciences Inc., Moderna Inc., Vertex Pharmaceuticals Incorporated, CRISPR Therapeutics AG, Editas Medicine Inc., bluebird bio Inc., Illumina Inc., Qiagen N.V., Lonza Group AG, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Becton Dickinson and Company, Sartorius AG, Abcam PLC, Horizon Discovery Group PLC, Integrated DNA Technologies Inc., Twist Bioscience Corporation, Synthego Corporation, Codex DNA Inc., InvivoGen, Eurofins Scientific SE, Sarepta Therapeutics Inc., Sangamo Therapeutics Inc.

North America was the largest region in the recombinant DNA technology market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recombinant dna technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the recombinant dna technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The recombinant DNA technology market includes revenues earned by entities by expression systems including mammalian, bacteria, yeast, and baculovirus / insect. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Recombinant DNA Technology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on recombinant dna technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for recombinant dna technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The recombinant dna technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Recombinant Protein Drugs; Vaccines; Genetically Modified Crops; Expression Systems; Cell And Gene Therapy; Gene Editing
2) By Component Type: Expression System; Cloning Vector
3) By Application Type: Food And Agriculture; Health And Disease; Environment; Other Application Types
4) By End-Use Type: Biotechnology And Pharmaceutical Companies; Academic And Government Research Institutes; Other End-Use Types
Subsegments:
1) By Recombinant Protein Drugs: Hormones; Growth Factors
2) By Vaccines: Recombinant Viral Vaccines; Recombinant Bacterial Vaccines; Subunit Vaccines
3) By Genetically Modified Crops: Herbicide-Tolerant Crops; Insect-Resistant Crops; Nutritionally Enhanced Crop
4) By Expression Systems: Bacterial Expression Systems; Yeast Expression Systems; Mammalian Expression Systems
5) By Cell And Gene Therapy: Cell-Based Therapies; Gene Replacement Therapies; CAR T-Cell Therapies
6) By Gene Editing: CRISPR Or Cas9 Technologies; TALENs (Transcription Activator-Like Effector Nucleases); ZFNs (Zinc Finger Nucleases)
Companies Mentioned: Profacgen BioTech Corp.; Amgen Inc.; Novartis International AG; GenScript Biotech Corporation; Pfizer Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r22904

1. Executive Summary

2. Recombinant DNA Technology Market Characteristics

3. Recombinant DNA Technology Market Trends And Strategies

4. Recombinant DNA Technology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Recombinant DNA Technology Growth Analysis And Strategic Analysis Framework

5.1. Global Recombinant DNA Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Recombinant DNA Technology Market Growth Rate Analysis
5.4. Global Recombinant DNA Technology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Recombinant DNA Technology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Recombinant DNA Technology Total Addressable Market (TAM)

6. Recombinant DNA Technology Market Segmentation

6.1. Global Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Protein Drugs
Vaccines
Genetically Modified Crops
Expression Systems
Cell and Gene Therapy
Gene Editing
6.2. Global Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Expression System
Cloning Vector
6.3. Global Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Food And Agriculture
Health And Disease
Environment
Other Application Types
6.4. Global Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biotechnology And Pharmaceutical Companies
Academic And Government Research Institutes
Other End-Use Types
6.5. Global Recombinant DNA Technology Market, Sub-Segmentation Of Recombinant Protein Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hormones
Growth Factors
6.6. Global Recombinant DNA Technology Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Viral Vaccines
Recombinant Bacterial Vaccines
Subunit Vaccines
6.7. Global Recombinant DNA Technology Market, Sub-Segmentation Of Genetically Modified Crops, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Herbicide-Tolerant Crops
Insect-Resistant Crops
Nutritionally Enhanced Crop
6.8. Global Recombinant DNA Technology Market, Sub-Segmentation Of Expression Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bacterial Expression Systems
Yeast Expression Systems
Mammalian Expression Systems
6.9. Global Recombinant DNA Technology Market, Sub-Segmentation Of Cell And Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cell-Based Therapies
Gene Replacement Therapies
CAR T-Cell Therapies
6.10. Global Recombinant DNA Technology Market, Sub-Segmentation Of Gene Editing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CRISPR or Cas9 Technologies
TALENs (Transcription Activator-Like Effector Nucleases)
ZFNs (Zinc Finger Nucleases)

7. Recombinant DNA Technology Market Regional And Country Analysis

7.1. Global Recombinant DNA Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Recombinant DNA Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Recombinant DNA Technology Market

8.1. Asia-Pacific Recombinant DNA Technology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Recombinant DNA Technology Market

9.1. China Recombinant DNA Technology Market Overview
9.2. China Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Recombinant DNA Technology Market

10.1. India Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Recombinant DNA Technology Market

11.1. Japan Recombinant DNA Technology Market Overview
11.2. Japan Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Recombinant DNA Technology Market

12.1. Australia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Recombinant DNA Technology Market

13.1. Indonesia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Recombinant DNA Technology Market

14.1. South Korea Recombinant DNA Technology Market Overview
14.2. South Korea Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Recombinant DNA Technology Market

15.1. Western Europe Recombinant DNA Technology Market Overview
15.2. Western Europe Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Recombinant DNA Technology Market

16.1. UK Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Recombinant DNA Technology Market

17.1. Germany Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Recombinant DNA Technology Market

18.1. France Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Recombinant DNA Technology Market

19.1. Italy Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Recombinant DNA Technology Market

20.1. Spain Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Recombinant DNA Technology Market

21.1. Eastern Europe Recombinant DNA Technology Market Overview
21.2. Eastern Europe Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Recombinant DNA Technology Market

22.1. Russia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Recombinant DNA Technology Market

23.1. North America Recombinant DNA Technology Market Overview
23.2. North America Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Recombinant DNA Technology Market

24.1. USA Recombinant DNA Technology Market Overview
24.2. USA Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Recombinant DNA Technology Market

25.1. Canada Recombinant DNA Technology Market Overview
25.2. Canada Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Recombinant DNA Technology Market

26.1. South America Recombinant DNA Technology Market Overview
26.2. South America Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Recombinant DNA Technology Market

27.1. Brazil Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Recombinant DNA Technology Market

28.1. Middle East Recombinant DNA Technology Market Overview
28.2. Middle East Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Recombinant DNA Technology Market

29.1. Africa Recombinant DNA Technology Market Overview
29.2. Africa Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Recombinant DNA Technology Market Competitive Landscape And Company Profiles

30.1. Recombinant DNA Technology Market Competitive Landscape
30.2. Recombinant DNA Technology Market Company Profiles
- 30.2.1. Profacgen BioTech Corp. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. GenScript Biotech Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Recombinant DNA Technology Market Other Major And Innovative Companies

31.1. Novo Nordisk A/S
31.2. Eli Lilly and Company
31.3. Sanofi S.A.
31.4. Merck & Co. Inc.
31.5. Biogen Inc.
31.6. GlaxoSmithKline PLC
31.7. New England Biolabs Inc.
31.8. Bayer CropScience
31.9. Thermo Fisher Scientific Inc.
31.10. F. Hoffmann-La Roche Ltd
31.11. Regeneron Pharmaceuticals Inc.
31.12. Gilead Sciences Inc.
31.13. Moderna Inc.
31.14. Vertex Pharmaceuticals Incorporated
31.15. CRISPR Therapeutics AG

32. Global Recombinant DNA Technology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Recombinant DNA Technology Market

34. Recent Developments In The Recombinant DNA Technology Market

35. Recombinant DNA Technology Market High Potential Countries, Segments and Strategies

35.1 Recombinant DNA Technology Market In 2029 - Countries Offering Most New Opportunities
35.2 Recombinant DNA Technology Market In 2029 - Segments Offering Most New Opportunities
35.3 Recombinant DNA Technology Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer